Rhelion Life Sciences’ Wholly Owned Subsidiary Filament Health Delivers PEX010 to Bruyere Health Research Institute’s Phase 3 Trial of Microdose Psilocybin in Palliative Care
Filament has shipped PEX010 to Bruyère Health Research Institute for its Phase 3 placebo-controlled trial, which follows a published Phase...